MUNTONI, ANNA LISA
MUNTONI, ANNA LISA
Istituto di Neuroscienze - IN - Sede Secondaria Monserrato (CA)
Functional Adaptation in the Brain Habenulo–Mesencephalic Pathway During Cannabinoid Withdrawal
2024 Aroni, S.; Sagheddu, C.; Pistis, M.; Muntoni, A. L.
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring
2023 Santoni, M.; Sagheddu, C.; Serra, V.; Mostallino, R.; Castelli, M. P.; Pisano, F.; Scherma, M.; Fadda, P.; Muntoni, A. L.; Zamberletti, E.; Rubino, T.; Melis, M.; Pistis, M.
The Atypical Dopamine Transporter Inhibitor CE-158 Enhances Dopamine Neurotransmission in the Prefrontal Cortex of Male Rats: A Behavioral, Electrophysiological, and Microdialysis Study
2023 Sagheddu, C.; Cancedda, E.; Bagheri, F.; Kalaba, P.; Muntoni, A. L.; Lubec, J.; Lubec, G.; Sanna, F.; Pistis, M.
Astrocytes mediate long-lasting synaptic regulation of ventral tegmental area dopamine neurons
2022 Maria Requie, Linda; Gomez-Gonzalo, Marta; Speggiorin, Michele; Managò, Francesca; Melone, Marcello; Congiu, Mauro; Chiavegato, Angela; Lia, Annamaria; Zonta, Micaela; Losi, Gabriele; JORGE HENRIQUES, Vanessa; Pugliese, Arianna; Pacinelli, Giada; Marsicano, Giovanni; Papaleo, Francesco; Muntoni, ANNA LISA; Conti, Fiorenzo; Carmignoto, Giorgio
Exposure to an enriched environment reduces alcohol self-administration in Sardinian alcohol-preferring rats
2022 Maccioni, P; Bratzu, J; Lobina, C; Acciaro, C; Corrias, G; Capra, A; Carai, Mam; Agabio, R; Muntoni, Al; Gessa, Gl; Colombo, G
Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPAR-alpha Agonist Fenofibrate-Treated Mice
2022 Murru, Elisabetta; Muntoni, ANNA LISA; Manca, Claudia; Aroni, Sonia; Pistis, Marco; Banni, Sebastiano; Carta, Gianfranca
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance
2021 Congiu, M; Micheli, L; Santoni, M; Sagheddu, C; Muntoni, Al; Makriyannis, A; Malamas, Ms; Ghelardini, C; Di Cesare Mannelli, L; Pistis, M
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders
2021 Sagheddu, C; Melis, M; Muntoni, Al; Pistis, M
delta 9 Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation
2019 Lecca, Salvatore; Luchicchi, Antonio; Scherma, Maria; Fadda, Paola; Muntoni, ANNA LISA; Pistis, Marco
The PPAR alpha agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia
2019 De Felice, Marta; Melis, Miriam; Aroni, Sonia; Muntoni, Anna Lisa; Fanni, Silvia; Frau, Roberto; Devoto, Paola; Pistis, Marco
Oltre gli endocannabinoidi: ruolo dei neuromodulatori lipidici nelle tossicodipendenze
2018 Congiu, M; Sagheddu, C; Melis, M; Muntoni, Al; Pistis, M
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy
2017 Puligheddu, M; Melis, M; Pillolla, G; Milioli, G; Parrino, L; Terzano, Gm; Aroni, S; Sagheddu, C; Marrosu, F; Pistis, M; Muntoni, Al
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases
2017 Pistis M.; Muntoni A.L.
Adolescent D9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats
2016 Scherma, M.; Dessì, C.; Muntoni, A.L.; Lecca, S.; Satta, V.; Luchicchi, L.; Pistis, M.; Panlilio, L.V.; Fattore, L.; Goldberg, S.R.; Fratta, W.; Fadda, P.
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives
2016 Scherma M.; Muntoni A.L.; Melis M.; Fattore L.; Fadda P.; Fratta W.; Pistis M.
Maternal immune activation disrupts dopamine system in the offspring
2016 Luchicchi A.; Lecca S.; Melis M.; De Felice M.; Cadeddu F.; Frau R.; Muntoni A.L.; Fadda P.; Devoto P.; Pistis M.
PPAR modulation of mesolimbic dopamine transmission rescues depression-related behaviors
2016 Scheggi S.; Melis M.; De Felice M.; Aroni S.; Muntoni A.L.; Pelliccia T.; Gambarana C.; De Montis M.G.; Pistis M.
The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission
2016 Mutti, A; Aroni, S; Fadda, P; Padovani, L; Mancini, L; Collu, R; Muntoni, Al; Fattore, L; Chiamulera, C
Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function
2015 Sagheddu, C; Muntoni, Al; Pistis, M; Melis, M
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain
2015 Sagheddu, C; Aroni, S; De Felice, M; Lecca, S; Luchicchi, A; Melis, M; Muntoni, Al; Romano, R; Palazzo, E; Guida, F; Maione, S; Pistis, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Functional Adaptation in the Brain Habenulo–Mesencephalic Pathway During Cannabinoid Withdrawal | 1-gen-2024 | Aroni, S.; Sagheddu, C.; Pistis, M.; Muntoni, A. L. | |
| Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring | 1-gen-2023 | Santoni, M.; Sagheddu, C.; Serra, V.; Mostallino, R.; Castelli, M. P.; Pisano, F.; Scherma, M.; Fadda, P.; Muntoni, A. L.; Zamberletti, E.; Rubino, T.; Melis, M.; Pistis, M. | |
| The Atypical Dopamine Transporter Inhibitor CE-158 Enhances Dopamine Neurotransmission in the Prefrontal Cortex of Male Rats: A Behavioral, Electrophysiological, and Microdialysis Study | 1-gen-2023 | Sagheddu, C.; Cancedda, E.; Bagheri, F.; Kalaba, P.; Muntoni, A. L.; Lubec, J.; Lubec, G.; Sanna, F.; Pistis, M. | |
| Astrocytes mediate long-lasting synaptic regulation of ventral tegmental area dopamine neurons | 1-gen-2022 | Maria Requie, Linda; Gomez-Gonzalo, Marta; Speggiorin, Michele; Managò, Francesca; Melone, Marcello; Congiu, Mauro; Chiavegato, Angela; Lia, Annamaria; Zonta, Micaela; Losi, Gabriele; JORGE HENRIQUES, Vanessa; Pugliese, Arianna; Pacinelli, Giada; Marsicano, Giovanni; Papaleo, Francesco; Muntoni, ANNA LISA; Conti, Fiorenzo; Carmignoto, Giorgio | |
| Exposure to an enriched environment reduces alcohol self-administration in Sardinian alcohol-preferring rats | 1-gen-2022 | Maccioni, P; Bratzu, J; Lobina, C; Acciaro, C; Corrias, G; Capra, A; Carai, Mam; Agabio, R; Muntoni, Al; Gessa, Gl; Colombo, G | |
| Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPAR-alpha Agonist Fenofibrate-Treated Mice | 1-gen-2022 | Murru, Elisabetta; Muntoni, ANNA LISA; Manca, Claudia; Aroni, Sonia; Pistis, Marco; Banni, Sebastiano; Carta, Gianfranca | |
| N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance | 1-gen-2021 | Congiu, M; Micheli, L; Santoni, M; Sagheddu, C; Muntoni, Al; Makriyannis, A; Malamas, Ms; Ghelardini, C; Di Cesare Mannelli, L; Pistis, M | |
| Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders | 1-gen-2021 | Sagheddu, C; Melis, M; Muntoni, Al; Pistis, M | |
| delta 9 Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation | 1-gen-2019 | Lecca, Salvatore; Luchicchi, Antonio; Scherma, Maria; Fadda, Paola; Muntoni, ANNA LISA; Pistis, Marco | |
| The PPAR alpha agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia | 1-gen-2019 | De Felice, Marta; Melis, Miriam; Aroni, Sonia; Muntoni, Anna Lisa; Fanni, Silvia; Frau, Roberto; Devoto, Paola; Pistis, Marco | |
| Oltre gli endocannabinoidi: ruolo dei neuromodulatori lipidici nelle tossicodipendenze | 1-gen-2018 | Congiu, M; Sagheddu, C; Melis, M; Muntoni, Al; Pistis, M | |
| Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy | 1-gen-2017 | Puligheddu, M; Melis, M; Pillolla, G; Milioli, G; Parrino, L; Terzano, Gm; Aroni, S; Sagheddu, C; Marrosu, F; Pistis, M; Muntoni, Al | |
| Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases | 1-gen-2017 | Pistis M.; Muntoni A.L. | |
| Adolescent D9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats | 1-gen-2016 | Scherma, M.; Dessì, C.; Muntoni, A.L.; Lecca, S.; Satta, V.; Luchicchi, L.; Pistis, M.; Panlilio, L.V.; Fattore, L.; Goldberg, S.R.; Fratta, W.; Fadda, P. | |
| Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives | 1-gen-2016 | Scherma M.; Muntoni A.L.; Melis M.; Fattore L.; Fadda P.; Fratta W.; Pistis M. | |
| Maternal immune activation disrupts dopamine system in the offspring | 1-gen-2016 | Luchicchi A.; Lecca S.; Melis M.; De Felice M.; Cadeddu F.; Frau R.; Muntoni A.L.; Fadda P.; Devoto P.; Pistis M. | |
| PPAR modulation of mesolimbic dopamine transmission rescues depression-related behaviors | 1-gen-2016 | Scheggi S.; Melis M.; De Felice M.; Aroni S.; Muntoni A.L.; Pelliccia T.; Gambarana C.; De Montis M.G.; Pistis M. | |
| The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission | 1-gen-2016 | Mutti, A; Aroni, S; Fadda, P; Padovani, L; Mancini, L; Collu, R; Muntoni, Al; Fattore, L; Chiamulera, C | |
| Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function | 1-gen-2015 | Sagheddu, C; Muntoni, Al; Pistis, M; Melis, M | |
| Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain | 1-gen-2015 | Sagheddu, C; Aroni, S; De Felice, M; Lecca, S; Luchicchi, A; Melis, M; Muntoni, Al; Romano, R; Palazzo, E; Guida, F; Maione, S; Pistis, M |